· 9/27/1999
Brumbaugh v. Sandoz Pharmaceutical Corp.
Citations
- 77 F. Supp. 2d 1153
- 1999 U.S. Dist. LEXIS 20824
- 1999 WL 1104539
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- noting that the most significant analytical defect of case reports is that they “don’t isolate and investigate the effects of alternative causation agents... [tjhey reflect reported data, not scientific methodology.”
- noting that the most significant analytical defect of case reports is that they “don’t isolate and investigate the effects of alternative causation agents, [t]hey reflect reported data, not scientific methodology”
- excluding plaintiffs expert’s testimony regarding Parlodel® because, inter alia no proof was presented to support his “causal mechanism theory”
- “Testimony extending general conclusions about ... drugs [similar to bromocriptine] does not meet Dau-bert’s requirement of reliability.”
- “[hjere, the limited probative worth of Dr. Iffy’s testimony is outweighed by the substantial probability of misleading the jury so the evidence is inadmissible pursuant to Fed.R.Evid. 403”
- \Testimony extending general conclusions about similar drugs does not meet Daubert's requirement of reliability.\
Source: CourtListener parenthetical corpus (CC0).
Judges: Molloy
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.